A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group (Q41692489)
scientific article published on October 1999
Language:
(P31) (Q13442814)
(P304) 776-783
(P407) (Q1860)
(P433) 4
(P478) 117
(P577) Friday, October 1, 1999
(P921) (Q62736)
(Q212809)
(P1433) (Q4039279)
(P1476) "A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group" (language: en)
(P2093) Laine L
Harper S
Simon T
Bath R
Johanson J
Schwartz H
Stern S
Quan H
Bolognese J
(P2283) (Q1231081)
(P2860) (Q71523193)
(Q54737121)
(Q34720605)
(Q24563699)
(Q71757419)
(Q39440579)
(Q77927267)
(Q73404066)
(Q24655364)
(Q68582794)
(Q46499838)
(Q44835028)
(Q68441561)
(Q55066041)
(Q77859984)
(Q72825123)
(Q72188612)
(Q69496911)
(Q33493399)
(Q34733169)
other details
description scientific article published on October 1999

External Links